Skip to main content
Livermore
Livermore
ZHEN

Syros Pharmaceuticals, Inc.

SYRSDelisted Mar 10, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001556263

Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Syros Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
65
−4 vs. Q2 2024
Shares held
19.0M
−1.17M (−5.8%) vs. Q2 2024
Total value
$40.8M
−$63.1M (−60.8%) vs. Q2 2024
New holders
13
10 more added
Sold out
17
15 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 65 institutions
Q1 2021: 106 institutionsQ2 2021: 100 institutionsQ3 2021: 100 institutionsQ4 2021: 90 institutionsQ1 2022: 94 institutionsQ2 2022: 69 institutionsQ3 2022: 53 institutionsQ4 2022: 57 institutionsQ1 2023: 59 institutionsQ2 2023: 53 institutionsQ3 2023: 48 institutionsQ4 2023: 58 institutionsQ1 2024: 75 institutionsQ2 2024: 70 institutionsQ3 2024: 65 institutionsQ4 2024: 44 institutionsQ1 2025: 7 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $40.8M
Q1 2021: $475.8MQ2 2021: $276.0MQ3 2021: $223.1MQ4 2021: $166.0MQ1 2022: $53.1MQ2 2022: $34.2MQ3 2022: $59.9MQ4 2022: $37.9MQ1 2023: $27.5MQ2 2023: $33.5MQ3 2023: $47.9MQ4 2023: $146.8MQ1 2024: $111.9MQ2 2024: $105.2MQ3 2024: $40.8MQ4 2024: $1.20MQ1 2025: $12.4KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SYRS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20257$12.4K
Q4 202444$1.20M
Q3 202465$40.8M
Q2 202470$105.2M
Q1 202475$111.9M
Q4 202358$146.8M
Q3 202348$47.9M
Q2 202353$33.5M
Q1 202359$27.5M
Q4 202257$37.9M
Q3 202253$59.9M
Q2 202269$34.2M
Q1 202294$53.1M
Q4 202190$166.0M
Q3 2021100$223.1M
Q2 2021100$276.0M
Q1 2021106$475.8M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q2 2024.

Institutions holding SYRS in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC2$40.00%+2New
Steward Partners Investment Advisory, LLC8$170.00%00.0%Unchanged
PSI Advisors, LLC13$280.00%00.0%Unchanged
Sound Income Strategies, LLC76$1630.00%00.0%Unchanged
Activest Wealth Management87$1870.00%00.0%Unchanged
Fifth Third Bancorp129$2770.00%00.0%Unchanged
Tower Research Capital LLC (TRC)246$5290.00%−2,606−91.4%Reduced
Wells Fargo & Company454$9760.00%00.0%Unchanged
JPMorgan Chase & Co549$1.18K0.00%00.0%Unchanged
Cubist Systematic Strategies, LLC595$1.28K0.00%−3,285−84.7%Reduced
Citigroup Inc687$1.48K0.00%+687New
Bank of America Corp705$1.52K0.00%−17,419−96.1%Reduced
Russell Investments Group, Ltd.750$1.61K0.00%00.0%Unchanged
Royal Bank of Canada1,100$2.00K0.00%−2,321−67.8%Reduced
Advisor Group Holdings, Inc.1,032$2.22K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.1,095$2.35K0.00%00.0%Unchanged
Morgan Stanley2,392$5.14K0.00%−7,307−75.3%Reduced
Federation des caisses Desjardins du Quebec4,500$9.68K0.00%00.0%Unchanged
Group One Trading, L.P.7,634$16.4K0.00%+1,234+19.3%Added
Aster Capital Management (DIFC) Ltd9,970$21.4K0.00%+9,970New
Integrated Wealth Concepts LLC10,000$21.5K0.00%00.0%Unchanged
Wiser Wealth Management, Inc10,000$21.5K0.01%+10,000New
Centerpoint Advisors, LLC10,659$23.0K0.01%+10,659New
CI Private Wealth, LLC12,000$25.8K0.00%00.0%Unchanged
Marex Group plc12,700$27.3K0.00%+12,700New
HighTower Advisors, LLC14,898$32.0K0.00%−450−2.9%Reduced
Gsa Capital Partners LLP15,905$34.0K0.00%+15,905New
UBS Group AG16,728$36.0K0.00%−4,825−22.4%Reduced
Clarius Group, LLC18,620$40.0K0.00%00.0%Unchanged
Virtu Financial LLC19,629$42.0K0.00%+19,629New
Price T Rowe Associates Inc22,550$49.0K0.00%00.0%Unchanged
Two Sigma Investments, LP28,475$61.2K0.00%−11,791−29.3%Reduced
XTX Topco Ltd28,834$62.0K0.00%+28,834New
Camden Capital, LLC29,825$64.1K0.01%+8,623+40.7%Added
Millennium Management LLC31,700$68.2K0.00%−31,314−49.7%Reduced
1492 Capital Management LLC39,244$84.4K0.04%00.0%Unchanged
Northern Trust Corp40,812$87.7K0.00%00.0%Unchanged
ADAR1 Capital Management, LLC45,000$96.8K0.02%+45,000New
Pale Fire Capital SE49,211$105.8K0.02%+49,211New
Bridgeway Capital Management, LLC51,500$110.7K0.00%00.0%Unchanged
Acadian Asset Management LLC52,866$113.0K0.00%+18,288+52.9%Added
State Street Corp69,430$149.3K0.00%00.0%Unchanged
Qube Research & Technologies Ltd77,716$167.1K0.00%+49,557+176.0%Added
Walleye Capital LLC86,641$186.3K0.00%−199,162−69.7%Reduced
Prelude Capital Management, LLC89,097$191.6K0.01%+48,800+121.1%Added
Renaissance Technologies LLC96,435$207.3K0.00%−21,000−17.9%Reduced
Perceptive Advisors LLC116,754$251.0K0.01%00.0%Unchanged
Marshall Wace, LLP160,390$344.8K0.00%00.0%Unchanged
Geode Capital Management, LLC204,695$440.3K0.00%−21,415−9.5%Reduced
Omega Fund Management, LLC251,270$540.2K0.34%00.0%Unchanged
BlackRock, Inc.261,579$562.4K0.00%+261,579New
Exome Asset Management LLC298,575$641.9K0.43%+139,400+87.6%Added
ExodusPoint Capital Management, LP313,004$673.0K0.01%+49,313+18.7%Added
UBS Oconnor LLC359,305$772.5K0.02%+81,202+29.2%Added
Blue Owl Capital Holdings LP515,855$1.11M0.22%+175,000+51.3%Added
Opaleye Management Inc.654,943$1.41M0.23%−210,500−24.3%Reduced
Deep Track Capital, LP828,485$1.78M0.06%00.0%Unchanged
Vanguard Group Inc953,313$2.05M0.00%−14,904−1.5%Reduced
Avidity Partners Management LP1,063,000$2.29M0.12%−610,538−36.5%Reduced
Flagship Pioneering Inc.1,293,849$2.78M0.47%00.0%Unchanged
Point72 Asset Management, L.P.1,471,771$3.16M0.01%00.0%Unchanged
Samsara BioCapital, LLC1,786,427$3.84M0.74%00.0%Unchanged
Adage Capital Partners GP, L.L.C.2,071,914$4.45M0.01%00.0%Unchanged
Siren, L.L.C.2,587,372$5.56M0.28%+2,587,372New
Bain Capital Life Sciences Investors, LLC2,750,151$5.91M0.62%+3430.0%Added
Artal Group S.A.0$00.00%−2,505,013−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−427,536−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−262,373−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−135,850−100.0%Sold out
LPL Financial LLC0$00.00%−76,625−100.0%Sold out
LGT Capital Partners Ltd.0$00.00%−55,000−100.0%Sold out
Jane Street Group, LLC0$00.00%−39,181−100.0%Sold out
Superstring Capital Management LP0$00.00%−37,789−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−30,005−100.0%Sold out
Citadel Advisors LLC0$00.00%−26,622−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−15,873−100.0%Sold out
Simplex Trading, LLC0$00.00%−14,091−100.0%Sold out
Edmond de Rothschild Holding S.A.0$00.00%−4,382−100.0%Sold out
Redwood Wealth Management Group, LLC0$00.00%−1,157−100.0%Sold out
National Bank of Canada0$00.00%−859−100.0%Sold out
Rhumbline Advisers0$00.00%−659−100.0%Sold out
Aviso Financial Inc.0$00.00%−21−100.0%Sold out
BlackRock Inc.––––Not filed